Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
The Importance of Aquaporin-4...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
Bibliográfalaš dieđut
Váldodahkkit:
Sato, D
,
Nakashima, I
,
Takahashi, T
,
Misu, T
,
Waters, P
,
Kuroda, H
,
Nishiyama, S
,
Suzuki, C
,
Takai, Y
,
Itoyama, Y
,
Fujihara, K
,
Aoki, M
Materiálatiipa:
Journal article
Almmustuhtton:
2013
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Dahkki: Sato, D, et al.
Almmustuhtton: (2013)
Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
Dahkki: Sato, D, et al.
Almmustuhtton: (2014)
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Dahkki: Nour, M, et al.
Almmustuhtton: (2015)
Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
Dahkki: Yoshiki Takai, et al.
Almmustuhtton: (2023-07-01)
CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
Dahkki: Chihiro Namatame, et al.
Almmustuhtton: (2021-01-01)